Hair loss treatment

Posts

Global Anti-dandruff Agent Ingredients Market

Selenium Sulfide Market Forecast to 2027

Selenium Sulfide Market Forecast to 2027

MARKET INTRODUCTION

Selenium sulfide belongs to a class of anti-infective agents. It functions by slowing the growth of fungi yeast which usually causes an infection. Selenium sulfide is used to treat hair problems especially dandruff and several scalp infections. Selenium sulfide helps to stop flaking, irritation, itching of the scalp. Selenium sulfide is available in the form of lotion and shampoo.

MARKET DYNAMICS

The key market drivers for the Selenium Sulfide Market Includes, rising demand for selenium sulfide in pharmaceutical industries due to its antifungal properties and applications for personal grooming, hair care products.

Moreover, the use of selenium sulfide in diseases like seborrheic dermatitis and dandruff care is also expected to fuel market growth. Additionally, risen demand for selenium sulfide in the chemical industry is also expected to boost market growth.

However, potential side effects from selenium sulfide are expected to restrain the market growth during the forecast period.

MARKET SCOPE

The “Selenium Sulfide Market” is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Selenium Sulfide market with detailed market segmentation by application and end-user. The Selenium Sulfide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in the Selenium Sulfide Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Selenium Sulfide Market is segmented on the basis of application and end-user. On the basis of application, the market is segmented as, an anti-infective agent, disease treatment and others. And on the basis of end-user, the market is segmented as, pharmaceuticals, commercial and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the Selenium Sulfide Market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Selenium Sulfide Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting Selenium Sulfide Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Selenium Sulfide Market in these regions.

MARKET PLAYERS

The report covers key developments in the Selenium Sulfide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of the business and customer base of market players.

The market players from Selenium Sulfide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Selenium Sulfide market in the global market. Below mentioned is the list of few companies engaged in the Selenium Sulfide Market.

The report also includes the profiles of key players in the Selenium Sulfide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of the last 3 years, key development in the past five years.

Omkar Speciality Chemicals
Phibrochem
Ochem
BOC Sciences
Tractus Company Limited
Macsen Laboratories
Orion
Muby Chemicals
Abbott Laboratories
Macsen Drugs

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Selenium Sulfide Market Forecast to 2027

Source

Recent Posts

Global Anti-dandruff Agent Ingredients Market

Selenium Sulfide Market Forecast to 2027

Selenium Sulfide Market Forecast to 2027

MARKET INTRODUCTION

Selenium sulfide belongs to a class of anti-infective agents. It functions by slowing the growth of fungi yeast which usually causes an infection. Selenium sulfide is used to treat hair problems especially dandruff and several scalp infections. Selenium sulfide helps to stop flaking, irritation, itching of the scalp. Selenium sulfide is available in the form of lotion and shampoo.

MARKET DYNAMICS

The key market drivers for the Selenium Sulfide Market Includes, rising demand for selenium sulfide in pharmaceutical industries due to its antifungal properties and applications for personal grooming, hair care products.

Moreover, the use of selenium sulfide in diseases like seborrheic dermatitis and dandruff care is also expected to fuel market growth. Additionally, risen demand for selenium sulfide in the chemical industry is also expected to boost market growth.

However, potential side effects from selenium sulfide are expected to restrain the market growth during the forecast period.

MARKET SCOPE

The “Selenium Sulfide Market” is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Selenium Sulfide market with detailed market segmentation by application and end-user. The Selenium Sulfide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in the Selenium Sulfide Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Selenium Sulfide Market is segmented on the basis of application and end-user. On the basis of application, the market is segmented as, an anti-infective agent, disease treatment and others. And on the basis of end-user, the market is segmented as, pharmaceuticals, commercial and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the Selenium Sulfide Market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Selenium Sulfide Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting Selenium Sulfide Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Selenium Sulfide Market in these regions.

MARKET PLAYERS

The report covers key developments in the Selenium Sulfide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of the business and customer base of market players.

The market players from Selenium Sulfide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Selenium Sulfide market in the global market. Below mentioned is the list of few companies engaged in the Selenium Sulfide Market.

The report also includes the profiles of key players in the Selenium Sulfide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of the last 3 years, key development in the past five years.

Omkar Speciality Chemicals
Phibrochem
Ochem
BOC Sciences
Tractus Company Limited
Macsen Laboratories
Orion
Muby Chemicals
Abbott Laboratories
Macsen Drugs

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Selenium Sulfide Market Forecast to 2027

Source

Recent Posts

Global Hair Transplant Industry

Hair Transplant Market Size

Hair Transplant Market Size study, by Product Type, By Application, and Regional Forecasts 2020-2026

HeyReport estimates that the Hair Transplant market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025 and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Hair Transplant industry and its cost structure.

Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
Follicular Unit Transplantation (FUT)
Follicular Unit Extraction (FUE)

Application Segmentation Includes

Hospitals
Clinics

Companies Includes

Bernstein Medical
Bosley
Ethics hair instruments
MEDICAMAT
Restoration Robotics

The main contents of the report including:

Section 1:
Product definition, type and application, Global & China market overview;

Section 2:
Global & China Market competition by company;

Section 3:
Global & China sales revenue, volume and price by type;

Section 4:
Global & China sales revenue, volume and price by application;

Section 5:
China export and import;

Section 6:
Company information, business overview, sales data and product specifications;

Section 7:
Industry chain and raw materials;

Section 8:
Industrial policies & economic environment

Section 9:

Conclusion.

For any other requirements, please feel free to contact HeyReport for customized contents.

Hair Transplant Market Size study, by Product Type, By Application, and Regional Forecasts 2020-2026

Source

Recent Posts

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Stem Cell and Platelet Rich Plasma Alopecia Therapies

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026t

This report focuses on the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Orange County Hair Restoration Center
Hair Sciences Center of Colorado
Anderson Center for Hair
Evolution Hair Loss Institute
Savola Aesthetic Dermatology Center
Virginia Surgical Center
Hair Transplant Institute of Miami
Colorado Surgical Center & Hair Institute

Market segment by Type, the product can be split into

Platelet Rich Plasma Injections
Stem Cell Therapy
Market segment by Application, split into
Dermatology Clinics
Hospitals

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies are as follows:

History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Summary:

Get the latest Market Research Reports on COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies. Industry analysis & Market Report on COVID-19 Impact on Global Stem

Cell and Platelet Rich Plasma (PRP) Alopecia Therapies is a syndicated market report, published as COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size,

Status and Forecast 2020-2026. It is a complete Research Study and Industry Analysis of COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market, to understand,

Market Demand, Growth, trends analysis and Factor Influencing market.

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026

Source

Recent Posts

Facial Hair Transplantation

Dr Bared Co-Authors Hair Transplant Surgery Textbook

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook

Dr Anthony Bared, a highly-respected Miami board-certified plastic surgeon and hair restoration specialist, has been published in the Hair Transplant Surgery and Platelet Rich Plasma textbook by editor Linda N. Nee.

The new handbook is suited for beginners to advanced surgeons in the rapidly-emerging field of hair transplantation.

Editor Linda N. Nee selected experts in facial plastic surgery and dermatology to write chapters in the text. Dr Anthony Bared, MD, wrote Chapter 10, Techniques in Beard and Eyebrow Restoration. The book begins with the basics and leads to advanced surgical tips with cutting-edge information.

Dr Lee, Dr Bared, and the other co-authors offer surgical tips needed by clinicians and surgeons to achieve natural-looking results.

Dr Bared specializes in beard restoration, which is an emerging trend in cosmetic surgery.

Patients visit Dr Bared in Miami, FL, to seek beard transplants for various reasons, including a desire for thicker facial hair due to genetic factors, to reverse laser hair removal, or to conceal facial burns, scarring, or cleft lip repair. Female to male transgender patients may also request information on facial hair restoration for a more masculine appearance.

Dr Bared customizes each transplant to match the patient’s desired shape and density. Men seeking facial hair transplantation typically have a specific idea of how they want their beard to appear, and Dr Bared asks them to be actively involved in the design process. Male patients may require a secondary procedure depending on the size and density of the desired beard.

At his Miami practice, Dr Bared also offers his advanced skills in eyebrow restoration, a popular treatment requested by men and women to perfect the eyebrow’s shape, density, and the hair’s natural direction and angle.

Eyebrow restoration is beneficial to women experiencing thinning eyebrows caused by genetics, over-plucking, or ageing. Some forms of alopecia, such as alopecia totalis (complete absence of the eyebrow), may affect eyebrow restoration candidacy. Men often lose the lateral aspect of the eyebrow due to ageing and desire thicker eyebrows for cosmetic reasons.

Men and women can bring photos of eyebrows and use eyeliner to fill in the brow for Dr Bared to see the look they want to achieve. The patient is actively involved in the design of their eyebrows.

Facial hair transplant specialist Dr Bared is double board-certified by the American Board of Plastic and Reconstructive Surgery and the American Board of Otolaryngology.

Advanced follicular unit extraction (FUE) techniques allow patients to avoid linear scars if they wear short haircuts. Dr Bared gives his patients flexibility and fantastic results using the FUE technique. He has performed over 1000 facial hair restoration procedures at his Miami practice.

If you are interested in a beard or eyebrow restoration request a consultation with Dr Anthony Bared, MD, FACS in Miami, Florida, or visit Facial Plastic Surgery Miami.

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook

Source

Recent Posts

Facial Hair Transplantation

Facial Hair Transplantation

Dr. Anthony Bared Takes Part in Facial Hair Transplantation

Acclaimed Miami plastic surgeon and hair transplant specialist Dr. Anthony Bared recently participated in a study conducted by PubMed, MEDLINE, and Embase databases on the topic of facial hair transplantation for transgender patients.

research was conducted by looking at studies published through April 2020 discussing facial hair transplant in transmasculine patients. The goal of the study, published by Oxford University Press (Aesthetic Surgery Journal 2021,1-10), was to review current literature around the topic of facial hair transplantation to offer best practices and recommendations for surgeons providing this life-changing procedure that is becoming increasingly popular.

By determining common threads in the medical literature, invaluable conclusions were drawn during the study that have the potential to benefit thousands of patients worldwide. The review process began by looking at literature from the databases of PubMed, Embase and MEDLINE. Data was gathered from all relevant studies through April of 2020 and broken down so that valuable meta-analysis could be conducted.

The data exported from these studies include demographics, outcomes, specific techniques, complications, side-effects and patient satisfaction. The results provided many useful conclusions that led Dr. Bared and his colleagues to create recommendations for surgeons serving transmasculine patients.

The study comes in the wake of the increasing demand for facial hair transplantation in transmasculine patients. Transmasculine patients, transgender individuals assigned female at birth but identifying as male, are a growing segment of the population seeking gender reassignment surgery. As such, research seeking to improve aesthetic factors in this group is seeing greater interest. Dr. Anthony Bared is an authority on plastic surgery and has a commitment to serving transgender patients.

Hair transplantation can play a life-changing role in the process of gender reassignment surgeries but tailoring the outcome to transmasculine patients requires greater specialization than most surgeons possess. Dr. Anthony Bared’s clinic has seen an increased influx of transgender patients seeking hair restoration in recent years. Procedures such as eyebrow transplantation, hairline lowering and pubic hair transplants are common for male-to-female patients.

On the other hand, female-to-male patients typically seek hair procedures that focus on beard and body hair. The study conducted by Dr. Bared and his colleagues provides valuable insight into the role that hair transplantation plays in the lives of transmasculine patients and maps out a surgical path to attaining optimal results.

Dr. Anthony Bared’s medical training started with Otolaryngology at the University of Miami. He was later awarded a highly competitive fellowship by the American Academy of Facial Plastic and Reconstructive Surgery. His credentials include being double board-certified by the American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery.

Dr. Bared’s office is located in Miami, FL. The doctor is recognized by patients and peers alike for his expertise in surgical and non-surgical procedures and treatments, especially hair transplantation.

Dr. Anthony Bared Takes Part in Facial Hair Transplantation

Source

Recent Posts

Global Alopecia Treatment Market

Speaker discusses use of JAK inhibitors in alopecia

Speaker discusses use of JAK inhibitors in alopecia

A speaker at South Beach Symposium Medical Dermatology Summit discussed the JAK inhibitors that are currently on the market and their applications in treating alopecia areata.

Antonella Tosti, MD, said that JAK inhibitors “are probably the future of treatment for alopecia areata.”

Of the three main JAK inhibitors used for alopecia areata — ruxolitinib, baricitinib and tofacitinib — tofacitinib “has been most studied,” Tosti said. The standard dose of tofacitinib is 5 mg twice daily.

Patients usually regrow hair about 3 months after beginning treatment, and even though some patients may take longer, they should “persist and continue the treatment,” she said.

About 70% of patients respond to tofacitinib, although it is typically less effective in long-standing alopecia totalis or alopecia universalis. However, the oral formulation is more effective than the topical formulation, Tosti said.

Large clinical trials for ruxolitinib and baricitinib are ongoing, according to Tosti. In the literature cited during the presentation, ruxolitinib doses were 10 mg twice daily and 10 mg every other day. She also said “usually ruxolitinib causes visible regrowth earlier than tofacitinib.”

There is not yet data on long-term side effects, but patients commonly experience upper respiratory infections, headache and weight gain. Given the potential danger of upper respiratory infections during the era of COVID-19, Tosti has advised her patients to discontinue treatment if they develop COVID-19 symptoms. Other side effects, such as severe infection, have been reported among patients taking a JAK inhibitor for another indication.

Tosti said there are several JAK inhibitor compounds in the phase 2 or 3 stage of development.

Speaker discusses use of JAK inhibitors in alopecia

Source

Recent Posts

Hair Transplant Expert Dr Epstein

Hair Transplant Expert Dr Epstein

Miami Hair Transplant Expert Dr Epstein Ranked Among the World’s Top 10 Hair Clinics

Dr. Jeffrey Epstein, M.D., FACS, FISHRS, is proud to be listed among the top ten hair restoration clinics worldwide by HairSite.com. HairSite is a one-of-a-kind patient statistics site that focuses only on hair transplant options and features the Top 10 Hair Restoration Hall of Fame.

HairSite worldwide map has collected over 3400 patient results from approximately 80 clinics worldwide and features this information for patients looking for realistic hair transplant options. Dr. Epstein is the founder and director of the Foundation for Hair Restoration and is listed in the Hall of Fame based on 87 patient reviews over nine uninterrupted years with HairSite.

Dr. Epstein is board-certified in facial plastic surgery and otolaryngology-head and neck surgery. He is also a Diplomat of the American Board of Hair Restoration Surgery and a fellow of the American College of Surgeons (FACS) and the International Society of Hair Restoration Surgery (FISHRS).

Dr. Epstein has over 25 years of experience and has helped thousands of patients restore their confidence through hair restoration. He performs all of the procedures requested by his patients, accompanied by a full-time staff of 10 expert assistants, including three nurse practitioners.

Dr. Epstein stays on top of cutting-edge research, including fat transfer and stem cell technology. He also educates the next generation of surgeons through his articles and lectures and serves as editor of the Hair Transplant Forum International, composed of more than 1200 surgeons worldwide.

Patients travel from around the world to visit Dr. Epstein. He has been performing hair restoration procedures since 1994 and has a loyal following with patients from over 80 countries and all 50 states. Dr. Epstein is a highly-qualified facial surgeon who is also recognized as one of the world’s best hair restoration surgeons.

He sees patients in Miami and NYC and provides virtual consultations by webcam for patients who want a customized hair restoration but live out of the state or the country. Although hair restoration procedures are not 100% predictable, Dr. Epstein’s patients have experienced a high success rate with an over 90% average.

Dr. Epstein is a hair restoration specialist who offers eyebrow transplants, follicular unit extraction (FUE) for thinning hair or baldness, facial hair transplants for beards, and hairline advancements to treat large foreheads or receding hairlines. Dr. Epstein is honored to be included by HairSite.com’s Top 10 Hair Restoration Hall of Fame based on his exceptional hair restoration results and patient satisfaction.

Miami Hair Transplant Expert Dr Epstein Ranked Among the World’s Top 10 Hair Clinics

Source

Recent Posts

HairMax Welcomes Mary Brunetti as Brand Ambassador

HairMax Welcomes Mary Brunetti as Brand Ambassador

HairMax Welcomes Mary Brunetti as Brand Ambassador to Provide Expert Guidance on Styling and Managing Multiple Causes of Thinning Hair Including Covid-19 Hair Loss

Mary is known as much for her celebrity clientele as she is for training world-class hairstylists. For nearly 20 years, Mary has implemented her unique training program at the Sally Hershberger salon in New York City, where she is the Director of Education.

Brunetti has been called upon to style the hair for many celebrities including, Bette Midler, Mariah Carey, Mariska Hargitay, Debra Messing, Eva Longoria, Carrie Underwood, Jane Krakowski, Brooke Shields, and Giada De Laurentiis, to name a few. Mary has styled hair backstage at Fashion Week for world-renowned designers such as Donna Karan, Nicole Miller, Naeem Kahn and Vivienne Westwood.

In addition, Brunetti’s work has been published in Vogue, Elle, Vanity Fair, New York magazine, Town & Country, Modern Bride, People, Mademoiselle as well as all the leading industry trade magazines including Modern Salon, American Salon and LaunchPad.

Mary maintains a clientele in her own Mary Brunetti Salon in the resort area of the Hamptons, N.Y., and continues to consult with top salons around the country on how to implement her tried and true training program.

Mary stated: “2020 brought many unexpected upheavals to the salon industry. Once we opened back up many of my clients began approaching me with their hair loss concerns, so I began looking into options.” Mary further stated, “In my research, I learned about the seven clinical studies that HairMax conducted on laser energy for hair growth, resulting in eight FDA clearances. I was wowed by science and the ongoing development of innovative technology for hair growth and hair wellness. I love the fact that as a Brand Ambassador for HairMax, I will be part of the solution that addresses a desperate situation for so many suffering from hair loss.”

“I only recommend products that I try myself, so I began using the LaserBand 82 hair growth device and saw the results. When it comes to hair growth and wellness, nothing compares to HairMax,” States Mary.

Francesca Dubsky, Director of Marketing stated: “There has been a significant uprise in reports of hair loss post-Covid-19, typically appearing 2-3 months after diagnosis. We have seen an increase in inquiries for information as to how to recognize and treat this occurrence. Mary joining us as Brand Ambassador will help educate people on how to deal with their Covid-19 related hair loss, as well as treatments for hereditary hair loss and how HairMax products can help them regrow and revitalize their hair.”

About HairMax:

Based in Boca Raton, Lexington Int’l is the pioneer and global leader in laser hair growth technology. HairMax Laser Devices are the first device on the market to receive FDA Clearance as a medical device to treat hair loss (androgenetic alopecia) and stimulate hair growth. HairMax Laser devices have been the subject of 7 clinical studies proving both efficacy and safety with an over 90% success rate. Study results have been published in 6 peer-reviewed medical journals. HairMax Laser devices have been granted 8 FDA Clearances and hold 14 medical device licenses world-wide.

HairMax Welcomes Mary Brunetti as Brand Ambassador to Provide Expert Guidance on Styling and Managing Multiple Causes of Thinning Hair Including Covid-19 Hair Loss

Source

Recent Posts

Global Hair Transplant Industry

Hair Transplant Services

Hair Transplant Services

Market Analysis of Hair Transplant Services-

The hair transplant services market is predicted to grow at a significant growth rate due to rising hair related problems. It has been observed that there has not been any specific age for hair related problems, as it can occur to any gender at any age.

This has created a huge market opportunity due to the large population pool having hair related problems and created the high demand deriving the hair transplant services market. Rising consciousness among a large number of the population regarding physical appearance is the main factor to boost the hair transplant services market.

Moreover, rising disposable income may also responsible for the rise in demand and may benefit the market to gain sufficient growth in the forecast years. The demand for hair transplant has grown tremendously due to a large number of the population facing hair loss, or hair related problems which have grown in the past few years, globally. It has been estimated that approx., 40-45% of women and 60-65% of men have hair related problems mainly hair loss because of multiple reasons such as genetics, stress, ageing, or illness.

Growing medical tourism for hair transplant services and treatment especially in some European counties like Turkey and India is one of the major key factors driving the growth of the hair transplant services market.

Turkey has more than 300 speciality clinics specialized in hair transplantation, growing the inbound population in Turkey and India from other European countries and regions increasing the revenue generation for the hair transplant services market.

Progressive technology, skilled healthcare professionals specialized in hair transplant and relatively economic hair transplant treatment are the main deriving factors responsible for increasing hair transplant market growth. However, some adverse side effects of drugs used in hair transplant treatment may hinder the market growth and may restrict the market expansion.

Some people who have undergone hair transplantation treatment have experienced itching and rashes after using drugs post-treatment. Sometimes the side effects can be worsening to loss of vision which is very rare. In the recent past year’s people with other side effects such as chest pain; swelling of lips, tongue, hand, and feet; weight gain, palpitation and loss of consciousness has been registered which is expected to hinder the demand for hair transplant treatment, hence, restricting the hair transplant services market.

The regions covered in this hair transplant services market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of hair transplant services is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players –

The major players operating in the hair transplant market are Aderans Company Limited, Bernstein Medical, Medicamat, Limmer Hair Transplant Center, PhotoMedex, Inc., Bosley, Cole Instruments, Ethics instruments, Medicamat, Restoration Robotics and others.

Rising Influences of Film and Fashion Industry Coupled with Efforts from Manufacturer Boosting the Market Growth

Manufacturers are making efforts to hold their strong market position in the hair transplant services market. Major Key players are more focusing on strategic approaches such as novel product launches, geographic expansion and their capacity; collaboration and partnerships are expected to propel the market with high growth and demand. For example, HairMax Inc. laser device has received ANVISA approval, which has been very advantageous for the company’s growth and expansion of its product portfolio.

Rising product approvals increases commercial availability and thus strengthen the market growth. Additionally, some of the other factors influencing and deriving the market growth are media influence, growth of film and fashion industry, peer pressure for beauty and appearance, etc. Some health factors also play an instrumental role in deriving market growth. These are accidents, genetic issues, diseases like cancer or chemotherapy which cause loss of hair coupled with the growing number of hair transplant clinics and services are propelling the market growth.

North America and Europe are expected to be the most Prominent Market for the Hair Transplant Services

Geographically, the Hair transplant services Market report is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America, followed by Europe market are expected to dominate the global hair transplant services market owing to technological advancement which delivers better hair transplant services are likely to grow the hair transplant services market. Furthermore, the introduction of a surgical hair transplant system such as ARTAS based on robotic technology has vastly shaped this market.

Also, rising fashion industry influences and advertisement has greatly benefited hair transplant services market growth. Additionally, the rising usage of hair transplant systems such as neograft which is performed in both men and women with the help of follicular unit extraction method is likely to boost the market growth in the coming years.

Key Benefits for Market Report–

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:-

By Treatment Type:

  • Laser Therapy
  • Stem Cell Therapy
  • Follicular Unit Transplant
  • Follicular Unit Extraction
  • Others

By Gender:

  • Female
  • Male

By End-User:

  • Hospitals
  • Hair Transplant Clinics
  • Outpatient Centers
  • Others

By Regional & Country Level:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Hair Transplant Services

Source

Recent Posts

Global Alopecia Treatment Market

Study Results for the Treatment of Androgenic Alopecia

Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men

Histogen today announced week 26 results from its Phase 1b/2a clinical trial of HST-001 in male patients with androgenic alopecia. At the week 26 timepoint, patients treated with HST-001 demonstrated a statistically significant change from baseline in total hairs (terminal and vellus) in the target area (TAHC) in the vertex as measured by Canfield’s Hairmetrix macrophotography system.

HST-001 was also shown to be safe and well-tolerated at week 26 as compared to placebo with no reports of serious adverse events. Similar to the week 18 primary endpoint results we reported in December of 2020, HST-001 did not achieve statistical significance at week 26 when compared to placebo.

“The recently completed study demonstrated that HST-001 was safe, well-tolerated, and exhibited signals of efficacy. This data will inform future development, and I look forward to working with Histogen and our other expert advisors as we plan and execute the next study in men with androgenetic alopecia,” said Dr Stacy Smith, M.D., founder of the California Dermatology and Clinical Research Institution and principal investigator for the HST-001 trial.

“We are encouraged that these results demonstrated that patients treated with HST-001 grow both terminal and vellus hairs in men with androgenic alopecia,” said Richard W. Pascoe, Histogen’s President and CEO. “Moreover, 84% of the subjects who received HST-001 responded to treatment over the 26-week period and the study drug was found to be safe and well-tolerated across all subjects.

With this data in hand, we have begun planning for a more substantive clinical trial in men with androgenic alopecia with the goal of determining the best clinical pathway for future registration trials. We anticipate the trial will commence in the second half of 2021.”

About the HST-001 Phase 1a/2b Study
This 2:1 randomized, blinded, the placebo-controlled, single-site study enrolled 36 male patients with androgenic alopecia with mild to moderate hair loss on a Norwood-Hamilton (N-H) Scale (3V, 4, 5), with a total of 30 evaluable patients at week 26.

It was designed to assess the safety and tolerability of HST-001, as well as indicators of efficacy at weeks 18 and 26. The primary study endpoint is an absolute change from baseline versus week 18 in total hairs (terminal and vellus) in the (TAHC) of the vertex as measured by Canfield’s Hairmetrix macrophotography system.

Secondary endpoints include absolute change from baseline in total hairs (terminal and vellus) new terminal and vellus hair count, hair thickness density and per cent change from baseline in TAHC, terminal and vellus hair counts in the vertex and right temporal regions at weeks 18 and 26, all as measured by Canfield’s Hairmetrix macrophotography system. At each treatment time point (Weeks 0, 6 and 12), patients received a total of 20 injections, 10 in the vertex scalp region and 5 in each temporal region for a total dose of 2mL.

About HST-001
HST-001, or Hair Stimulating Complex (HSC), is intended to be a physician-administered therapeutic for hair loss. HSC is anticipated to be a relatively safe, minimally invasive treatment that promotes new hair growth where existing treatments only reduce hair loss. HSC is manufactured to enrich for growth factors including KGF, VEGF and follistatin, which are involved in signaling stem cells in the body and have been shown to be important in hair formation and the stimulation of resting hair follicles.

About Histogen
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function.

Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

For more information, please visit www.histogen.com.

Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men

Source

Recent Posts